Description

The Institute for Safe Medication Practices (ISMP) has been highlighting errors and harmful events related to parenteral nutrition (PN) for nearly two decades. Most recently, the long-standing shortages of PN products have worsened the risk for errors in the prescribing, preparation, and administration of these sterile compounds. During this time, ISMP has seen an increase in the reported number of errors and workarounds. In addition, among other strategies to conserve limited resources, organizations have been forced to reduce the number of days they provide PN to patients. In other cases, organizations may elect to utilize alternative products, such as multi-chamber bag parenteral nutrition (MCP-PN), a standardized, commercially available parenteral nutrition product that requires fewer compounding steps before administration. Two chamber and three chamber bags may provide a safety advantage for specific patient populations and during parenteral nutrient product shortages

This program will discuss the benefits of learning the risks and error prevention strategies related to compounding parenteral nutrition, the place in therapy for MCB-PN including target patient populations (e.g., adult, chronically ill, critically ill) and settings (e.g., critical care, home), hearing firsthand experience how to integrate the use of MCB-PN into practice, and review the role that alternative lipids plays in nutrition.

Intended Audience

• Nurses
• Dieticians
• Pharmacists
• Pharmacy Technicians
• Physicians 

Learning Objectives

• Describe three risks associated with preparation of parenteral nutrition. 
• Explain the place in therapy and steps to safely implement use of multi-chamber bag parenteral nutrition.
• Describe alternative lipid sources and their use in parenteral nutrition therapy

Funding Source: This activity is supported by Fresenius Kabi.